Lung Diseases, Obstructive  >>  Veramyst (fluticasone furoate nasal spray)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Veramyst (fluticasone furoate nasal spray) / GSK
NCT02064504 / 2009-013801-33: Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination

Completed
1
48
RoW
GSK961081, Fluticasone furoate
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
05/14
05/14

Download Options